The company has significantly outperformed the broader market over the past year. Analysts remain optimistic about the stock's future prospects. Recently, the stock jumped 7.0% in a single week. While earnings growth is currently tracking behind the impressive five-year shareholder returns, the overall market performance and analyst outlook are positive. The company continues to be a notable performer within the healthcare sector.